September 27, 2019 - Posts

Whistleblower Roundup – September 27th, 2019

A look back at the week’s news and developments affecting whistleblowers.


Whistleblower Complaint Leads to Trump Impeachment Inquiry

A whistleblower complaint, from a member of the intelligence community, has emerged this past week detailing how President Trump allegedly used his official powers to coerce Ukraine into opening a criminal investigation into former Vice President Joseph R. Biden Jr. To read more about the whistleblower complaint, click here and here to read New York Times coverage of the story.


Pharmaceutical Company Targeting Elderly Victims Resolves False Claims Act Violations

Avanir Pharmaceuticals has agreed to pay over $108 million to settle False Claims Act allegations that they were involved in a kickback scheme targeting elderly patients in order to induce prescriptions of its drug Nuedexta, the Department of Justice announced this week. The civil settlement resolves three lawsuits filed under the qui tam, or whistleblower, provisions of the False Claims Act. The whistleblowers will receive between $5 to $12 million of the settlement. To read the full DOJ press release, click here.


Listen to: “Whistleblowing is Really in Our DNA: A History of Reporting Wrongdoing” by NPR

NPR details the history of whistleblowing, dating back to America’s first whistleblower protection law in 1778 and current whistleblowing trends. Allison Stanger, author of Whistleblowers: Honesty in America from Washington to Trump stated, “We’re a leader in this realm and whistleblowing is really in our DN. So that’s why this particular moment is so interesting.” To read and listen to this story, click here.



To learn more about our Whistleblower & Qui Tam practice click here. Our firm is located in Nashville, Tennessee but we represent whistleblowers all around the country. Call us today at (615) 244-2202.

Get in touch

Contact us today for a free consultation. We are here to work for you!